Historical data shows that a consistent $500 monthly investment into Regeneron Pharmaceuticals, Inc. (REGN) starting in 2020 would have turned a total investment of $49K into $53K today. This represents a total return of 8.5% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
Regeneron Pharmaceuticals, Inc. pays a dividend (currently yielding ~0.01%). By utilizing a Dividend Reinvestment Plan (DRIP), generated dividends automatically purchase fractional shares. Over this 6-year period, regular dividend payments totaled $430. Reinvesting these dividends continuously compounded your returns, accelerating the portfolio's growth far beyond simple price appreciation.
REGN vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,REGN underperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $87K, compared to REGN's $53K.